Why Most Type 2 Diabetes Diagnoses Come Years After the Damage Already Started

A type 2 diabetes diagnosis tends to feel sudden. A routine bloodwork panel comes back with an elevated A1C, and suddenly there’s a new label, a new prescription, and a new set of instructions. But the diagnosis itself is rarely the beginning of the problem. In most cases, it’s closer to the end of a long, quiet progression that started years earlier.

Diagnosis Is a Threshold, Not a Starting Point

Type 2 diabetes is typically diagnosed once A1C crosses a specific clinical threshold — generally 6.5% or higher. But insulin resistance, the underlying mechanism that eventually produces that elevated A1C, doesn’t appear overnight at that line. It develops gradually, often over five to ten years, moving through a long stretch classified as “prediabetes” or, in many cases, not flagged at all because standard annual labs weren’t measuring the right markers closely enough to catch it.

By the time A1C crosses the diagnostic threshold, the underlying insulin resistance has often been present, and progressively worsening, for a substantial portion of that decade.

Why Standard Screening Misses the Early Window

Most routine physicals include a basic glucose check, sometimes paired with an A1C if there’s already a reason for concern. These tests are designed to catch diabetes once it’s present, not to flag the early stages of insulin resistance before glucose control breaks down. Someone can have significantly elevated insulin levels, declining insulin sensitivity, and active fat-storage changes for years while their fasting glucose and A1C still read as “normal” or borderline.

This is part of why diabesity-related symptoms often get individually dismissed: fatigue is chalked up to stress, weight gain is chalked up to age or metabolism slowing down, and cravings are chalked up to a lack of discipline — when all three may be downstream effects of the same developing insulin resistance.

What Tends to Get Missed Along the Way

Looking back, many people diagnosed with type 2 diabetes can identify a string of earlier signs that, in hindsight, were part of the same progression:

• Gradual weight gain concentrated around the midsection, despite no major change in habits
• Increasing afternoon energy crashes, especially after carbohydrate-heavy meals
• Borderline lab results that were noted as “keep an eye on this” without further action
• A family history of type 2 diabetes that wasn’t factored into earlier screening decisions
• Slowly rising blood pressure or cholesterol markers that are part of the same metabolic cluster

None of these individually triggers a diabetes workup. Together, they’re a pattern.

Diagnosis criteria exist to confirm disease that’s already present. They were never designed to catch it on the way in.

Why Catching This Earlier Changes the Trajectory

The earlier insulin resistance is identified and addressed, the more responsive the underlying metabolic dysfunction tends to be to intervention. Years of progressive insulin resistance gradually reduce pancreatic capacity and worsen cellular insulin sensitivity; intervening before that progression goes too far generally means a wider range of outcomes is still on the table, including meaningful improvement in insulin sensitivity and, for some, the possibility of remission.

This is the core argument for biomarker-based risk scoring rather than waiting for a diagnostic threshold to be crossed. A score built specifically to measure insulin resistance — rather than a screening process built to confirm diabetes once it’s already present — can surface the pattern years before a standard physical would.